Among the remaining four genes (CCND1, LMO1, MDM4, and NCOA3), we observed no amplification or overexpression of MDM4, which is amplified and overexpressed in glioma and retinoblastoma6, in our analysis of 1,454 tumors. The gene discussed is LMO1; the disease is central nervous system cancer.